Join Growin Stock Community!

Accuray incorporatedARAY.US Overview

US StockHealthcare
(No presentation for ARAY)
My Watchlist

Ticker

Value

empty

There is no following symbol in this watchlist.

ARAY AI Insights

ARAY Overall Performance

ARAY AI Analysis & Strategy

AI Strategy

Browsing restrictions can be lifted for a fee.

ARAY Recent Performance

-3.69%

Accuray incorporated

0.05%

Avg of Sector

-0.31%

S&P500

ARAY PowerScanner

Introduction >>

Power Squeeze

Surfing Trend

1 Day

1 Week

1 Month

ARAY Key Information

ARAY Financial Forecast

chart

Browsing restrictions can be lifted for a fee.

QuarterlyEPS ForecastQoQMaxMin
2026Q1
2026Q2
2026Q3
2026Q4
2027Q1

ARAY Profile

Accuray Incorporated designs, develops, manufactures, and sells radiosurgery and radiation therapy systems for the treatment of tumors in the United States, Canada, Latin America, Australia, New Zealand, Europe, the Middle East, India, Africa, Japan, China, and rest of the Asia Pacific region. It offers the CyberKnife System, a robotic stereotactic radiosurgery and stereotactic body radiation therapy system used for the treatment of primary and metastatic tumors outside the brain, including tumors on or near the spine and in the breast, kidney, liver, lung, pancreas, and prostate. The company also provides the TomoTherapy System, including the Radixact System, which allows for integrated radiation treatment planning, delivery, and data management, enabling clinicians to deliver ultra-precise treatments to approximately 50 patients per day; iDMS data management system, a fully integrated treatment planning and data management systems; and Accuray precision treatment planning system, a treatment planning and data management systems. In addition, it offers post-contract customer support, installation, training, and other professional services. The company primarily markets its products directly to customers, including hospitals and stand-alone treatment facilities through its sales organization, as well as to customers through sales agents and group purchasing organizations in the United States; and to customers directly and through distributors and sales agents internationally. Accuray Incorporated was incorporated in 1990 and is headquartered in Madison, Wisconsin.

Price of ARAY

ARAY FAQ

This disclaimer is provided by TradingValley Inc. and includes any messages, news, research, analysis, prices or other information provided by the Company's website, the application "Growin App" and other services provided through the Company's website. It is only general market information for educational and investment decision-making reference, and does not constitute any investment advice. View Growin Disclaimer

ARAY Earnings Table

Unit : USD

QTRNon-GAAP EPSEPS YoYEPS Surprise %SalesSales YoYSales Surprise %NPM
Current
2025Q4
2025Q3
2025Q2
2025Q1
METRIC
VALUE
vs. INDUSTRY
EPS (TTM)
-0.30
PE Ratio (TTM)
-
Forward PE
4.10
PS Ratio (TTM)
0.16
PB Ratio
1.30
Price-to-FCF
-
METRIC
VALUE
vs. INDUSTRY
Gross Margin
27.74%
Net Margin
-8.15%
Revenue Growth (YoY)
-3.57%
Profit Growth (YoY)
-15.75%
3-Year Revenue Growth
-3.78%
3-Year Profit Growth
-17.56%
METRIC
VALUE
vs. INDUSTRY
EPS (TTM)
-0.30
PE Ratio (TTM)
-
Forward PE
4.10
PS Ratio (TTM)
0.16
PB Ratio
1.30
Price-to-FCF
-
Gross Margin
27.74%
Net Margin
-8.15%
Revenue Growth (YoY)
-3.57%
Profit Growth (YoY)
-15.75%
3-Year Revenue Growth
-3.78%
3-Year Profit Growth
-17.56%

  • When is ARAY's latest earnings report released?

    The most recent financial report for Accuray incorporated (ARAY) covers the period of 2026Q2 and was published on 2025/12/31. This report is prepared according to IFRS/US GAAP standards and includes key financial indicators—Revenue, Profitability, Cash Flow, and Capital Structure. This information is essential for investors evaluating ARAY's short-term business performance and financial health. For the latest updates on ARAY's earnings releases, visit this page regularly.

  • What is the operating profit of ARAY?

    According to the latest financial report, Accuray incorporated (ARAY) reported an Operating Profit of -11.57M with an Operating Margin of -11.31% this period, representing a decline of 345.72% compared to the same period last year. Operating Profit reflects the company's core business efficiency and cost control, making it a key indicator for evaluating operational strength and profitability.

  • How is ARAY's revenue growth?

    In the latest financial report, Accuray incorporated (ARAY) announced revenue of 102.24M, with a Year-Over-Year growth rate of -11.99%. Revenue growth can be driven by product mix changes, market share expansion, price adjustments, or international market penetration. Investors should also monitor gross margin and regional revenue distribution for a comprehensive view of growth quality and sustainability.

  • How much debt does ARAY have?

    As of the end of the reporting period, Accuray incorporated (ARAY) had total debt of 174.23M, with a debt ratio of 0.39. Long-term debt comprises a higher/lower proportion. The level of financial leverage directly impacts the company's capital structure and interest coverage. If debt is high, pay attention to interest expenses and refinancing risks. Conversely, a low-leverage structure indicates greater risk tolerance but potentially less growth flexibility.

  • How much cash does ARAY have?

    At the end of the period, Accuray incorporated (ARAY) held Total Cash and Cash Equivalents of 47.87M, accounting for 0.11 of total assets. Both current and quick ratios indicate robust short-term debt repayment ability. High cash reserves typically mean the company has strong liquidity, supporting operational needs, expansion investments, or shareholder returns.

  • Does ARAY go with three margins increasing?

    In the latest report, Accuray incorporated (ARAY) did not achieve the “three margins increasing” benchmark, with a gross margin of 23.5%%, operating margin of -11.31%%, and net margin of -13.5%%. This demonstrates limited improvement in profitability, which is a key signal for fundamental analysis. Investors should consider margin trends alongside other financial indicators to assess ARAY's profit trajectory and future growth potential.

  • Is ARAY's EPS continuing to grow?

    According to the past four quarterly reports, Accuray incorporated (ARAY)'s earnings per share (EPS) shows a declining trend, with the latest EPS at -0.11. If EPS continues to rise due to revenue growth and cost optimization, it can support P/E valuation recovery and attract long-term investors.

  • What is the FCF of ARAY?

    Accuray incorporated (ARAY)'s Free Cash Flow (FCF) for the period is -21.58M, calculated as Operating Cash Flow minus Capital Expenditures, representing a fall of 9,442.86% compared with the previous period. Positive FCF growth provides stable funding for dividends, debt repayment, or strategic acquisitions, and is an important measure of true profitability and shareholder return potential.

  • What are the PEG ratio and PE ratio of ARAY?

    The latest valuation data shows Accuray incorporated (ARAY) has a Price-To-Earnings (PE) ratio of -1.7 and a Price/Earnings-To-Growth (PEG) ratio of 0.05. A PEG below 1 usually suggests the market is underestimating growth potential, while a PEG above 1 indicates high growth expectations are already priced in. Investors should conduct a comprehensive valuation by considering historical growth, market forecasts, and industry cycles.